Is Eplerenone available in China? Is it covered by medical insurance?
Eplerenone (Eplerenone), as an aldosterone receptor antagonist, is of great significance in the treatment of hypertension and heart failure. By modulating the effects of the hormone aldosterone, it can help lower blood pressure and improve heart function, thereby improving patients' quality of life and cardiovascular health. However, patients should follow their doctor's advice when using it and conduct regular health monitoring.
Eplerenone has recently been approved by the State Food and Drug Administration for marketing in China, but it is not included in medical insurance. Patients may not be able to purchase it domestically yet. Please consult the local hospital pharmacy for information. There are original and generic versions of eplerenone available abroad. The original drug is mainly Turkish original drug, with a specification of 50mg*30tablets of about 150yuan. Generic drugs include Bangladeshi generic drugs and Indian generic drugs. The specifications are 50mg*100 tablets and the price is around 520~600 yuan.

However, use eplerenone with caution. Before use, doctors usually consider the patient's medical history, use of other medications, and any possible drug interactions. In addition, eplerenone may cause some adverse reactions, such as hyperkalemia (excessive potassium ion concentration in the body), dizziness, fatigue, etc. Therefore, patients should be monitored regularly while using the drug to ensure its safety and efficacy.
The main mechanism of action of eplerenone is to reduce the effect of aldosterone by antagonizing aldosterone receptors. Aldosterone is a hormone produced mainly in the kidneys that increases sodium reabsorption and potassium excretion, leading to an imbalance of electrolytes in the body, especially sodium retention and potassium loss, which may lead to hypertension and cardiovascular disease. Eplerenone helps prevent these adverse effects by reducing the effects of aldosterone, thereby reducing the risk of high blood pressure and cardiovascular disease.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)